Cargando…

Akt and mTOR in B Cell Activation and Differentiation

Activation of phosphoinositide 3-kinase (PI3K) is required for B cell proliferation and survival. PI3K signaling also controls key aspects of B cell differentiation. Upon engagement of the B cell receptor (BCR), PI3K activation promotes Ca(2+) mobilization and activation of NFκB-dependent transcript...

Descripción completa

Detalles Bibliográficos
Autores principales: Limon, Jose J., Fruman, David A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Research Foundation 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3412259/
https://www.ncbi.nlm.nih.gov/pubmed/22888331
http://dx.doi.org/10.3389/fimmu.2012.00228
_version_ 1782239946675847168
author Limon, Jose J.
Fruman, David A.
author_facet Limon, Jose J.
Fruman, David A.
author_sort Limon, Jose J.
collection PubMed
description Activation of phosphoinositide 3-kinase (PI3K) is required for B cell proliferation and survival. PI3K signaling also controls key aspects of B cell differentiation. Upon engagement of the B cell receptor (BCR), PI3K activation promotes Ca(2+) mobilization and activation of NFκB-dependent transcription, events which are essential for B cell proliferation. PI3K also initiates a distinct signaling pathway involving the Akt and mTOR serine/threonine kinases. It has been generally assumed that activation of Akt and mTOR downstream of PI3K is essential for B cell function. However, Akt and mTOR have complex roles in B cell fate decisions and suppression of this pathway can enhance certain B cell responses while repressing others. In this review we will discuss genetic and pharmacological studies of Akt and mTOR function in normal B cells, and in malignancies of B cell origin.
format Online
Article
Text
id pubmed-3412259
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Frontiers Research Foundation
record_format MEDLINE/PubMed
spelling pubmed-34122592012-08-10 Akt and mTOR in B Cell Activation and Differentiation Limon, Jose J. Fruman, David A. Front Immunol Immunology Activation of phosphoinositide 3-kinase (PI3K) is required for B cell proliferation and survival. PI3K signaling also controls key aspects of B cell differentiation. Upon engagement of the B cell receptor (BCR), PI3K activation promotes Ca(2+) mobilization and activation of NFκB-dependent transcription, events which are essential for B cell proliferation. PI3K also initiates a distinct signaling pathway involving the Akt and mTOR serine/threonine kinases. It has been generally assumed that activation of Akt and mTOR downstream of PI3K is essential for B cell function. However, Akt and mTOR have complex roles in B cell fate decisions and suppression of this pathway can enhance certain B cell responses while repressing others. In this review we will discuss genetic and pharmacological studies of Akt and mTOR function in normal B cells, and in malignancies of B cell origin. Frontiers Research Foundation 2012-08-06 /pmc/articles/PMC3412259/ /pubmed/22888331 http://dx.doi.org/10.3389/fimmu.2012.00228 Text en Copyright © 2012 Limon and Fruman. http://www.frontiersin.org/licenseagreement This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in other forums, provided the original authors and source are credited and subject to any copyright notices concerning any third-party graphics etc.
spellingShingle Immunology
Limon, Jose J.
Fruman, David A.
Akt and mTOR in B Cell Activation and Differentiation
title Akt and mTOR in B Cell Activation and Differentiation
title_full Akt and mTOR in B Cell Activation and Differentiation
title_fullStr Akt and mTOR in B Cell Activation and Differentiation
title_full_unstemmed Akt and mTOR in B Cell Activation and Differentiation
title_short Akt and mTOR in B Cell Activation and Differentiation
title_sort akt and mtor in b cell activation and differentiation
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3412259/
https://www.ncbi.nlm.nih.gov/pubmed/22888331
http://dx.doi.org/10.3389/fimmu.2012.00228
work_keys_str_mv AT limonjosej aktandmtorinbcellactivationanddifferentiation
AT frumandavida aktandmtorinbcellactivationanddifferentiation